Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1953 2
1958 1
1959 1
1960 1
1961 1
1963 1
1964 3
1965 1
1966 1
1967 1
1968 3
1969 3
1970 3
1971 1
1972 6
1973 3
1974 6
1975 3
1976 7
1977 5
1978 5
1979 6
1980 8
1981 7
1982 3
1983 6
1984 14
1985 13
1986 4
1987 14
1988 11
1989 17
1990 18
1991 26
1992 22
1993 19
1994 16
1995 23
1996 35
1997 21
1998 37
1999 23
2000 24
2001 30
2002 36
2003 32
2004 23
2005 48
2006 49
2007 49
2008 63
2009 85
2010 70
2011 93
2012 84
2013 94
2014 105
2015 89
2016 77
2017 83
2018 87
2019 62
2020 94
2021 119
2022 105
2023 103
2024 92
2025 75

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,038 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
Mankikian J, Caille A, Reynaud-Gaubert M, Agier MS, Bermudez J, Bonniaud P, Borie R, Brillet PY, Cadranel J, Court-Fortune I, Crestani B, Debray MP, Gomez E, Gondouin A, Hirschi-Santelmo S, Israel-Biet D, Jouneau S, Juvin K, Leger J, Kerjouan M, Marquette CH, Naccache JM, Nunes H, Plantier L, Prevot G, Quetant S, Traclet J, Valentin V, Uzunhan Y, Wémeau-Stervinou L, Bejan-Angoulvant T, Cottin V, Marchand-Adam S; EVER-ILD investigators and the OrphaLung network. Mankikian J, et al. Among authors: gomez e. Eur Respir J. 2023 Jun 8;61(6):2202071. doi: 10.1183/13993003.02071-2022. Print 2023 Jun. Eur Respir J. 2023. PMID: 37230499 Free article. Clinical Trial.
Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects.
Workman MJ, Lim RG, Wu J, Frank A, Ornelas L, Panther L, Galvez E, Perez D, Meepe I, Lei S, Valencia V, Gomez E, Liu C, Moran R, Pinedo L, Tsitkov S, Ho R, Kaye JA; Answer ALS Consortium; Thompson T, Rothstein JD, Finkbeiner S, Fraenkel E, Sareen D, Thompson LM, Svendsen CN. Workman MJ, et al. Among authors: gomez e. Neuron. 2023 Apr 19;111(8):1191-1204.e5. doi: 10.1016/j.neuron.2023.01.010. Epub 2023 Feb 9. Neuron. 2023. PMID: 36764301 Free PMC article.
Efficacy and Safety of Pembrolizumab in Combination With Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer: A Phase 2 Nonrandomized Clinical Trial.
Zsiros E, Lynam S, Attwood KM, Wang C, Chilakapati S, Gomez EC, Liu S, Akers S, Lele S, Frederick PJ, Odunsi K. Zsiros E, et al. Among authors: gomez ec. JAMA Oncol. 2021 Jan 1;7(1):78-85. doi: 10.1001/jamaoncol.2020.5945. JAMA Oncol. 2021. PMID: 33211063 Free PMC article. Clinical Trial.
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Díaz-González Á, Hernández-Guerra M, Pérez-Medrano I, Sapena V, Riveiro-Barciela M, Barreira-Díaz A, Gómez E, Morillas RM, Del Barrio M, Escudé L, Mateos B, Horta D, Gómez J, Conde I, Ferre-Aracil C, El Hajra I, Arencibía A, Zamora J, Fernández A, Salcedo M, Molina E, Soria A, Estévez P, López C, Álvarez-Navascúes C, García-Retortillo M, Crespo J, Londoño MC; ColHai Registry. Díaz-González Á, et al. Among authors: gomez e. Hepatology. 2023 Apr 1;77(4):1095-1105. doi: 10.1097/HEP.0000000000000018. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36626622 Free article.
Polished diamond X-ray lenses.
Celestre R, Antipov S, Gomez E, Zinn T, Barrett R, Roth T. Celestre R, et al. Among authors: gomez e. J Synchrotron Radiat. 2022 May 1;29(Pt 3):629-643. doi: 10.1107/S1600577522001795. Epub 2022 Mar 15. J Synchrotron Radiat. 2022. PMID: 35510996 Free PMC article.
Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer.
Ruiz-Fernández de Córdoba B, Valencia K, Welch C, Moreno H, Martínez-Canarias S, Zandueta C, Gómez E, Calvo A, Otegui N, Echepare M, Garzón I, Ajona D, Lara-Astiaso D, Guruceaga E, Guembe L, Pío R, Melero I, Vicent S, Pastor F, Martínez-Monge R, Lecanda F. Ruiz-Fernández de Córdoba B, et al. Among authors: gomez e. Signal Transduct Target Ther. 2025 Jun 13;10(1):185. doi: 10.1038/s41392-025-02271-2. Signal Transduct Target Ther. 2025. PMID: 40506449 Free PMC article.
Electronic plants.
Stavrinidou E, Gabrielsson R, Gomez E, Crispin X, Nilsson O, Simon DT, Berggren M. Stavrinidou E, et al. Among authors: gomez e. Sci Adv. 2015 Nov 20;1(10):e1501136. doi: 10.1126/sciadv.1501136. eCollection 2015 Nov. Sci Adv. 2015. PMID: 26702448 Free PMC article.
Pharmaceuticals in the environment.
Halm-Lemeille MP, Gomez E. Halm-Lemeille MP, et al. Among authors: gomez e. Environ Sci Pollut Res Int. 2016 Mar;23(6):4961-3. doi: 10.1007/s11356-016-6248-6. Epub 2016 Mar 8. Environ Sci Pollut Res Int. 2016. PMID: 26951222 Free article. No abstract available.
2,038 results